All In Biotech

Drug Trial Radar · NCT04433585

A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus

Last checked: Nov 20, 2026Latest source record: Apr 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 291 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

291

Actual

Start

Aug 19, 2020

Primary completion

Jan 10, 2023

Study completion Feb 16, 2023

Sponsor

Lead sponsor
Nektar TherapeuticsIndustry
Sponsor type
Industry
Collaborators
Eli Lilly and Company
First posted
Jun 16, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The reason for this study is to see if the study drug LY3471851 (NKTR-358) is safe and effective in adults with systemic lupus erythematosus (SLE).

Conditions

  • Systemic Lupus Erythematosus

Interventions

  • LY3471851Drug

    Administered SC

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who Achieved a ≥4 Point Reduction in Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) 2000 (2K) Score at Week 24Time frame: Week 24

Locations

112 sites in 19 countries. Site status is shown where the registry gives one.

  • University of California - San Diego

    La Jolla, California

  • Desert Medical Advances

    Palm Desert, California

  • Stanford University Hospital

    Stanford, California

  • Inland Rheumatology & Osteoporosis Medical Group

    Upland, California

  • University of Colorado School of Medicine

    Aurora, Colorado

  • Clinical Research Center of CT/NY

    Danbury, Connecticut

  • Yale University School of Medicine

    New Haven, Connecticut

  • Stamford Therapeutics Consortium

    Stamford, Connecticut

  • University of Miami School of Medicine

    Miami, Florida

  • New Horizon Research Center

    Miami, Florida

  • NECCR PrimaCare Research

    Fall River, Massachusetts

  • Washington University School of Medicine

    St Louis, Missouri

  • Northwell Health

    Great Neck, New York

  • NYU Langone

    New York, New York

  • MetroHealth Medical Center

    Cleveland, Ohio

  • Paramount Medical Research

    Middleburg Heights, Ohio

  • Oklahoma Medical Research Foundation

    Oklahoma City, Oklahoma

  • Accurate Clinical Management

    Baytown, Texas

  • Metroplex Clinical Research Center

    Dallas, Texas

  • University of Texas Southwestern Medical Center at Dallas

    Dallas, Texas

  • Accurate Clinical Research

    Houston, Texas

  • Fort Bend Clinical Research, LLC

    Sugar Land, Texas

  • University of Washington Medical Center

    Seattle, Washington

  • Hospital J. M. Ramos Mejía

    Ciudad Autónoma de Buenos Aire, Argentina

  • Hospital Córdoba

    Córdoba, Argentina

  • Centro Polivalente de Asistencia e Inv. Clinica CER-San Juan

    San Juan, Argentina

  • DOM- Centro de Reumatologia

    CABA, Buenos Aires, Argentina

  • Centro Privado de Medicina Familiar / Mindout Research

    Ciudad Autónoma de Buenos Aire, Buenos Aires, Argentina

  • APRILLUS Asistencia E Investigacion de Arcis Salud

    CABA, Ciudad Autónoma de Buenos Aire, Argentina

  • Clinica Adventista Belgrano

    CABA, Ciudad Autónoma de Buenos Aire, Argentina

  • Centro de Investigaciones Médicas Tucuman

    SAN M. de Tucuman, Tucumán Province, Argentina

  • Emeritus Research

    Camberwell, Victoria, Australia

  • University of Calgary

    Calgary, Alberta, Canada

  • INREA s.r.o.

    Ostrava, Ostrava Město, Czechia

  • Revmatologicky ustav

    Prague, Praha, Hlavní Mešto, Czechia

  • Universitätsklinikum Köln

    Cologne, Germany

  • Klinik für Innere Medizin I, Universitätsklinikum Schleswig-Holstein, Campus Kiel

    Kiel, Germany

  • Universitätsklinikum Tübingen

    Tübingen, Baden-Wurttemberg, Germany

  • Universtitätsklinikum Essen AöR

    Essen, North Rhine-Westphalia, Germany

  • Rheumazentrum Ruhrgebiet

    Herne, North Rhine-Westphalia, Germany

Showing 40 of 112 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.